123 related articles for article (PubMed ID: 15696966)
41. Molecular genetic analysis of deep-seated glioblastomas.
Hayashi Y; Yamashita J; Watanabe T
Cancer Genet Cytogenet; 2004 Aug; 153(1):64-8. PubMed ID: 15325097
[TBL] [Abstract][Full Text] [Related]
42. FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.
Nagasaka T; Gunji M; Hosokai N; Hayashi K; Ikeda H; Ito M; Inao S
Brain Tumor Pathol; 2007; 24(1):1-5. PubMed ID: 18095137
[TBL] [Abstract][Full Text] [Related]
43. Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas.
Knobbe CB; Trampe-Kieslich A; Reifenberger G
Neuropathol Appl Neurobiol; 2005 Oct; 31(5):486-90. PubMed ID: 16150119
[TBL] [Abstract][Full Text] [Related]
44. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
[TBL] [Abstract][Full Text] [Related]
45. Genetic alterations in primary glioblastomas in Japan.
Fukushima T; Favereaux A; Huang H; Shimizu T; Yonekawa Y; Nakazato Y; Ohagki H
J Neuropathol Exp Neurol; 2006 Jan; 65(1):12-8. PubMed ID: 16410744
[TBL] [Abstract][Full Text] [Related]
46. Microarray-based comparative genomic hybridization (array-CGH) as a useful tool for identifying genes involved in Glioblastoma (GB).
Ruano Y; Mollejo M; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
Methods Mol Biol; 2010; 653():35-45. PubMed ID: 20721736
[TBL] [Abstract][Full Text] [Related]
47. The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years.
Korshunov A; Sycheva R; Golanov A
Cancer; 2005 Aug; 104(4):825-32. PubMed ID: 15981281
[TBL] [Abstract][Full Text] [Related]
48. The rate of homozygous CDKN2A/p16 deletions in glioma cell lines and in primary tumors.
Hartmann C; Kluwe L; Lücke M; Westphal M
Int J Oncol; 1999 Nov; 15(5):975-82. PubMed ID: 10536182
[TBL] [Abstract][Full Text] [Related]
49. Primary and secondary glioblastomas: from concept to clinical diagnosis.
Kleihues P; Ohgaki H
Neuro Oncol; 1999 Jan; 1(1):44-51. PubMed ID: 11550301
[TBL] [Abstract][Full Text] [Related]
50. Comparative genomic hybridization reveals recurrent enhancements on chromosome 20 and in one case combined amplification sites on 15q24q26 and 20p11p12 in glioblastomas.
Brunner C; Jung V; Henn W; Zang KD; Urbschat S
Cancer Genet Cytogenet; 2000 Sep; 121(2):124-7. PubMed ID: 11063794
[TBL] [Abstract][Full Text] [Related]
51. Chromosomal and genetic aberrations differ with meningioma subtype.
Wada K; Maruno M; Suzuki T; Kagawa N; Hashiba T; Fujimoto Y; Hashimoto N; Izumoto S; Yoshimine T
Brain Tumor Pathol; 2004; 21(3):127-33. PubMed ID: 15696974
[TBL] [Abstract][Full Text] [Related]
52. Characterization of molecular genetic alterations in GBMs highlights a distinctive molecular profile in young adults.
Jha P; Suri V; Singh G; Jha P; Purkait S; Pathak P; Sharma V; Sharma MC; Suri A; Gupta D; Mahapatra AK; Sarkar C
Diagn Mol Pathol; 2011 Dec; 20(4):225-32. PubMed ID: 22089350
[TBL] [Abstract][Full Text] [Related]
53. p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
Yoon KS; Lee MC; Kang SS; Kim JH; Jung S; Kim YJ; Lee JH; Ahn KY; Lee JS; Cheon JY
J Korean Med Sci; 2001 Aug; 16(4):481-8. PubMed ID: 11511795
[TBL] [Abstract][Full Text] [Related]
54. Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma.
López-Ginés C; Navarro L; Muñoz-Hidalgo L; Buso E; Morales JM; Gil-Benso R; Gregori-Romero M; Megías J; Roldán P; Segura-Sabater R; Almerich-Silla JM; Monleón D; Cerdá-Nicolás M
Cell Oncol (Dordr); 2017 Aug; 40(4):389-399. PubMed ID: 28631186
[TBL] [Abstract][Full Text] [Related]
55. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours.
Mollenhauer J; Wiemann S; Scheurlen W; Korn B; Hayashi Y; Wilgenbus KK; von Deimling A; Poustka A
Nat Genet; 1997 Sep; 17(1):32-9. PubMed ID: 9288095
[TBL] [Abstract][Full Text] [Related]
56. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.
Nencha U; Rahimian A; Giry M; Sechi A; Mokhtari K; Polivka M; Schmitt Y; Di Stefano AL; Alentorn A; Labussière M; Sanson M
J Neurooncol; 2016 Feb; 126(3):441-6. PubMed ID: 26608520
[TBL] [Abstract][Full Text] [Related]
57. The importance of genomic copy number changes in the prognosis of glioblastoma multiforme.
Arslantas A; Artan S; Oner U; Müslümanoğlu H; Durmaz R; Cosan E; Atasoy MA; Başaran N; Tel E
Neurosurg Rev; 2004 Jan; 27(1):58-64. PubMed ID: 12845540
[TBL] [Abstract][Full Text] [Related]
58. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses.
Schröck E; Thiel G; Lozanova T; du Manoir S; Meffert MC; Jauch A; Speicher MR; Nürnberg P; Vogel S; Jänisch W
Am J Pathol; 1994 Jun; 144(6):1203-18. PubMed ID: 8203461
[TBL] [Abstract][Full Text] [Related]
59. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
Frederick L; Wang XY; Eley G; James CD
Cancer Res; 2000 Mar; 60(5):1383-7. PubMed ID: 10728703
[TBL] [Abstract][Full Text] [Related]
60. Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.
Labussière M; Boisselier B; Mokhtari K; Di Stefano AL; Rahimian A; Rossetto M; Ciccarino P; Saulnier O; Paterra R; Marie Y; Finocchiaro G; Sanson M
Neurology; 2014 Sep; 83(13):1200-6. PubMed ID: 25150284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
